Society of Interventional Radiology Apr 13 2026 A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives when treated with MRI‑guided, transurethral ultrasound ablation (TULSA) compared with robotic prostate surgery. The results of the CAPTAIN Trial were presented today Sunday at the SIR 2026 Annual Scientific Meeting in Toronto. The study followed 212 men treated at 23 medical